The proposed budget released Monday would have winners and losers in Medicare; President Donald Trump's budget, a messaging statement, contains healthcare cuts; veterans in California risk eviction from veterans homes if they intend to use an aid-in-dying law.
President Trump’s budget plan would help some Medicare beneficiaries more than others, the Associated Press reported. About a million beneficiaries with the highest prescription drug costs, whose individual bills reach a total of more than $8418 apiece, will come out on top. But about 4.5 million seniors whose total bills range between $3750 and $8418 could end up spending about $1000 more, because the budget proposes a change in how Medicare accounts for manufacturer discounts received by those patients.
The White House fiscal 2019 budget is largely considered a messaging document with no chance of passage, coming as Congress moves ahead with its own spending plan, The New York Times reported. However, the budget proposes again to “repeal and replace” the Affordable Care Act and to eliminate the law’s expansion of Medicaid. More than 30 states have already expanded Medicaid and GOP efforts to end the law failed in last year. The budget also proposes cuts of $69.5 billion over 10 years in projected Medicare payments to hospitals for “uncompensated care”; more than $95 billion over 10 years from nursing homes and home health agencies; $22 billion from Medicare Advantage plans; and $48 billion over 10 years in Medicare payments to teaching hospitals for graduate medical education.
A controversy is brewing in California where the law that allows terminally ill people to take lethal drugs to end their lives is running into conflict with a regulation that bars residents in veterans homes from using it, Kaiser Health News reported. Advocates of medical aid-in-dying and residents of the Veterans Home of California-Yountville are protesting the regulation from the California Department of Veterans Affairs that requires that anyone living in the facilities to be discharged if they intend to use the law.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More